Document is current

Any future updates will be listed below

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)

Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P40

Published Online: 2014-11-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark